Category: St. Jude MedicalSyndicate content

CardioMEMS' 11-year payoff worth the wait for Boston Millennia Partners

July 31, 2014 by Brian Johnson

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

The CardioMEMS story didn't end when St. Jude Medical (NYSE:STJ) acquired the Georgia-based company in June, paying $375 million for the stake it didn’t already own, valuing the implantable heart failure monitor company at $463 million total.

Michigan judge shoots down settlement alleged by Biomet in poaching spat with Stryker | Medtech legal news for the week of July 28, 2014

July 28, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Judge nixes alleged settlement in Stryker, Biomet poaching spat; Boston Scientific loses bids to exclude testimony in pelvic mesh trials; Occlutech claims another win over St. Jude Medical; Align Tech declares a 'total win' as federal circuit reverses ITC ruling; Report: Medtronic shareholder sues to block Covidien merger

Judge nixes alleged settlement in Stryker, Biomet poaching spat

July 23, 2014 by Brad Perriello

Layoffs: St. Jude cuts 274 in California

July 25, 2014 by Arezu Sarvestani

St. Jude Medical informs California state regulators that it's planning to lay off 274 from a facility in Sylmar.

Layoffs: St. Jude cuts 274 from California plant

St. Jude Medical (NYSE:STJ) is about to hand out more than 270 pink slips to employees at a facility in Sylmar, Calif., according to a notice filed with the state's Employment Development Dept.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Occlutech claims another win over St. Jude Medical

July 23, 2014 by Brad Perriello

Occlutech says a U.K. court invalidated a patent held by St. Jude Medical covering atrial septal occluder technology.

Occlutech claims another win over St. Jude Medical

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Press Release: St. Jude Medical announces CE Mark approval and 1st use of the FlexAbility ablation catheter

July 22, 2014 by MassDevice

European approval of next-generation ablation catheter further strengthens St. Jude Medical's fast-growing ablation technology portfolio.

Press Release: St. Jude Medical announces CE Mark approval and first use of the FlexAbility ablation catheter

St. Jude lands E.U. nod for flexible ablation catheter

July 22, 2014 by Arezu Sarvestani

Minnesota medtech giant St. Jude Medical touts 1st use of its FlexAbility ablation catheter after landing approval from European regulators.

St. Jude lands E.U. nod for flexible ablation catheter

European regulators put their stamp of approval on St. Jude Medical's (NYSE:STJ) new FlexAbility ablation catheter, paving the way to 1st use of the next-generation device.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study links St. Jude's Medical's Riata lead externalizations to electrical failures

July 17, 2014 by Brad Perriello

A Danish study of St. Jude Medical's recalled Riata and Riata ST defibrillator leads suggests that the externalization problem that led to the recall worsens over time and is linked to "electrical abnormalities."

Study links St. Jude's Medical's Riata lead externalizations to electrical failures
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp